ImmunityBio Inc.'s $10.5 million agreement to settle an investor class action alleging misrepresentations about a cancer drug ...

Find the latest ARS Pharma news from Fast company. See related business and technology articles, photos, slideshows and videos.

ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Dr. Melanie Orthodontics announces the opening of its new Rancho Santa Fe office on March 3, serving the North San Diego County communities. The location at 16236 San Dieguito Road #4-12 is the second ...

MedTrainer, a leading provider in healthcare workforce compliance solutions, is the winner of two Stevie® Awards for Sales & Customer Service. MedTrainer's customer support team is setting a new ...

ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation’s ...

We recently compiled a list of the 12 Stocks Under $10 With High Upside Potential. In this article, we are going to take a ...

Private Advisor Group LLC trimmed its position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 75.4% during the 4th ...

ImmunityBio (IBRX) faces operational, financial, and competitive challenges, impacting its growth prospects despite Anktiva's ...

With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but ...